5 min
Trying to Stay Ahead of Coronavirus Variants, Companies Still Rushing to Develop COVID Drugs Reopening America
-
- Salud y forma física
Companies are still in a rush working on drugs that can help treat COVID-19 and stay ahead of new, more transmissible variants that are popping up all over. Monoclonal antibody drugs are administered intravenously making them a little cumbersome, and some are working on new ones that are more accessible and maybe given as a shot. Joseph Walker, reporter at the WSJ, joins us for the race to stay ahead of coronavirus mutations.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information.
Companies are still in a rush working on drugs that can help treat COVID-19 and stay ahead of new, more transmissible variants that are popping up all over. Monoclonal antibody drugs are administered intravenously making them a little cumbersome, and some are working on new ones that are more accessible and maybe given as a shot. Joseph Walker, reporter at the WSJ, joins us for the race to stay ahead of coronavirus mutations.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information.
5 min